Results 21 to 30 of about 1,315,331 (224)

Comparison between Amulet and Watchman left atrial appendage closure devices: A real-world, single center experience

International Journal of Cardiology: Heart & Vasculature, 2021
Background: Data reporting a head-to-head comparison between Amulet and Watchman devices are scarce. The aim of this study was to compare the Watchman™ versus Amulet™ left atrial appendage closure (LAAC) devices in a consecutive, industry-independent ...
Mohammed Saad, Osama Risha, Makoto Sano, Thomas Fink, Christian-Hendrik Heeger, Julia Vogler, Vanessa Sciacca, Charlotte Eitel, Thomas Stiermaier, Alexander Joost, Ahmad Keelani, Georg Fuernau, Roza Meyer-Saraei, Karl-Heinz Kuck, Ingo Eitel, Roland Richard Tilz   +15 more
doaj   +1 more source

Computed Tomography Scan Evidence for Left Atrial Appendage Short‐Term Remodeling Following Percutaneous Occlusion: Impact of Device Oversizing

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background The interrelationships between left atrial appendage (LAA) dimensions and device following implantation are unknown. We aimed to analyze the impact of Watchman device implantation on LAA dimensions following its percutaneous closure and ...
Khalil Mahmoudi, Roberto Galea, Simon Elhadad, Fabrice Temperli, Frederic Sebag, Christoph Gräni, Zhor Rezine, Laurent Roten, Quentin Landolff, Nicolas Brugger, Alaa Masri, Lorenz Räber, Nicolas Amabile   +12 more
doaj   +1 more source

Combined atrial fibrillation ablation and left atrial appendage closure: Watchman vs. LAmbre devices

Frontiers in Cardiovascular Medicine, 2022
BackgroundLeft atrial appendage closure (LAAC) combined with radiofrequency catheter ablation is an emerging one-stop hybrid procedure for non-valvular atrial fibrillation (AF).
Jin-Yan Ke, Lu-Shen Jin, Yuan-Nan Lin, Jing Xu, Wei-Ke Liu, Jia-Yang Fu, Ling Li, Yi-Lian Chen, Yi-Xuan Qiu, Yue-Chun Li   +9 more
doaj   +1 more source

Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial. [PDF]

, 2022
Background: No study has so far compared Amulet with the new Watchman FLX in terms of residual left atrial appendage (LAA) patency or clinical outcomes in patients undergoing percutaneous LAA closure (LAAC).
Heg, Dik, Teiger, Emmanuel, Galea, Roberto, Iriart, Xavier, Babongo Bosombo, Flora, Fischer, Urs, Huber, Adrian T., Bedogni, Francesco, Aminian, Adel, Vranckx, Pascal, Pedrazzini, Giovanni, Meneveau, Nicolas, Anselme, Frédéric, Franzone, Anna, Räber, Lorenz, Bosombo, Flora Babongo, Gräni, Christoph, De Marco, Federico, Valgimigli, Marco   +18 more
core   +3 more sources

Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry

Frontiers in Cardiovascular Medicine, 2023
IntroductionThe Watchman FLX is a novel device for transcatheter left atrial appendage occlusion (LAAO) specifically designed to improve procedural performance in more complex anatomies with a better safety profile.
Sergio Berti, Alberto Ranieri De Caterina, Carmelo Grasso, Gavino Casu, Giuseppe Giacchi, Paolo Pagnotta, Paolo Pagnotta, Michele Maremmani, Patrizio Mazzone, Luca Limite, Francesco Tomassini, Francesco Greco, Maria Rita Romeo, Giuseppe Caramanno, Gaetano Fassini, Salvatore Geraci, Mauro Chiarito, Mauro Chiarito, Claudio Tondo, Corrado Tamburino, Marco Contarini   +20 more
doaj   +1 more source

Association between rates of ischemic stroke and all-cause mortality with the Watchman device compared to warfarin and direct oral anticoagulants in patients with atrial fibrillation [PDF]

Baylor University Medical Center Proceedings
Brittany Miles, Bright Etumuse
exaly   +2 more sources

Transition from WATCHMAN V.2.5 to WATCHMAN FLX for closure of the left atrial appendage: echocardiographic and clinical findings

Open Heart, 2023
Introduction Interventional closure of the left atrial appendage (LAAC) has been established as an alternative treatment for patients with atrial fibrillation (AF) and an elevated risk of stroke.
Henning Ebelt, Peter Roehl, Andreas Schwenzky, Matthias Hoyme, Charlotte Sakriss   +4 more
doaj   +1 more source

Safety and efficacy of low-dose non-vitamin K antagonist oral anticoagulants versus warfarin after left atrial appendage closure with the Watchman device

Journal of the Formosan Medical Association, 2022
Background/Purpose: Anticoagulant therapy is suggested within 45 days after Watchman device implantation for stroke prevention in patients with atrial fibrillation (AF).
Guohua Fu, Binhao Wang, Bin He, Yibo Yu, Zhao Wang, Mingjun Feng, Jing Liu, Xianfeng Du, Weidong Zhuo, Huimin Chu   +9 more
doaj   +1 more source

Left ventricular assist device percutaneous deactivation with a Watchman device

, 2021
International audienceMyocardial recovery in left ventricular assist device patients is a rare event. Surgical explantation remains a risky and challenging procedure. Alternative percutaneous techniques could represent an effective solution.
Rioufol, G., Obadia, J. F., Pozzi, M., Rioufol, Gilles, Pozzi, Matteo, Baudry, G., Baudry, Guillaume, Aoun, T., Obadia, Jean Francois, Aoun, Tanous   +9 more
core   +1 more source

Who watches the WATCHMAN? A rare case of lower extremity paralysis

Journal of the American College of Emergency Physicians Open, 2023
We present a case study involving an elderly patient who experienced dislodgement of a recently implanted WATCHMAN device. Initially, the patient exhibited multiple musculoskeletal symptoms, which raised concerns about alternative causes such as cauda ...
Terryce Blanchard, Keenan Hacker, Justin Grill, Joseph Betcher   +3 more
doaj   +1 more source